Isodiol International Inc (ISOLF)
Isodiol International Inc. is a healthcare company focused on hemp-based consumer products and related solutions in Canada and the United States. The company develops and manufactures phytoceutical products using pharmaceutical- and nutraceutical-grade phytochemical compounds, including cannabinoid crystalline isolates derived from exempt parts of the hemp plant. Its activities also include micro-encapsulation and nanotechnology applications for ingestible and topical skin care products. In addition, Isodiol is involved in the production and distribution of hemp oil, nicotine e-liquids, personal care products, hemp-infused beverages, apparel and merchandising solutions, and certain pharmaceutical products. The company is headquartered in Vancouver, Canada, and its common stock trades on OTC Markets.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-ISOL.F
|
Not available
|
Not available
|
Not available
|
Good
|
0.0%
|
0.128 K
|